Objective
Biomarkers are considered as tools to enhance cardiovascular risk estimation. However, the value of biomarkers on risk estimation beyond European risk scores, their comparative impact among different European regions and their role in the drive towards personalised medicine remains uncertain.
Based on harmonised and standardised European population cohorts we have built significant research collaboration, expertise and infrastructure in the EU. We will apply highly innovative SME-driven technologies and perform large-scale biomarker determination to assess the predictive value of existing and emerging biomarkers.
Selection of emerging biomarkers will be based on integrated cutting-edge quantitative proteomic, transcriptomic, metabolomic, and miRNomic datasets established by private and public consortium members that will be disclosed to this consortium. Existing biomarkers will be selected based on non-redundancy and their association with cardiovascular risk and phenotypes. After SME-guided development of innovative assay systems biomarkers will be tested and validated in a stepwise fashion among European populations in primary and secondary prevention. In addition to their impact on risk prediction, their association with lifestyle determinants and cardiovascular phenotypes assessed by ultrasound and MRI technique will be evaluated.
We will establish a BiomarCaRE panel which leads to improved disease prediction among different European populations. International collaborations with world-class clinical trial investigators will add data on the interaction of the BiomarCaRE panel with risk-lowering medication and lifestyle changes. The outcome of SME-driven technology development and clinical validation will undergo a medical technology assessment. The determination of cost-effectiveness will guide further clinical evaluation. These studies will reveal new methods of improved cardiovascular risk estimation and will open the path towards personalised medicine.
Fields of science
Call for proposal
FP7-HEALTH-2011-two-stage
See other projects for this call
Funding Scheme
CP-FP - Small or medium-scale focused research projectCoordinator
20251 Hamburg
Germany
See on map
Participants (29)
00271 Helsinki
See on map
3511 GC Utrecht
See on map
3584 CX Utrecht
See on map
85764 Neuherberg
See on map
6020 Innsbruck
See on map
23562 Lubeck
See on map
6060 Hall In Tyrol
See on map
30625 Hannover
See on map
RG27 8DH Hartley Wintney Hants
See on map
Participation ended
1015 Lausanne
EC1V 4PY London
See on map
55131 Mainz
See on map
9019 Tromso
See on map
20123 Milano
See on map
17489 Greifswald
See on map
WC1E 6BT London
See on map
BT7 1NN Belfast
See on map
59019 Lille
See on map
08025 Barcelona
See on map
901 87 Umea
See on map
51005 Tartu
See on map
3400 Hillerod
See on map
21100 Varese
See on map
DD1 4HN Dundee
See on map
4031 Basel
See on map
89081 Ulm
See on map
Participation ended
L8S 4L8 Hamilton
2006 Sydney
See on map
86077 Pozzilli Is
See on map